Semler Scientific/$SMLR

13:30
03:10
16:45
06:25
20:00
1D1W1MYTD1Y5YMAX

About Semler Scientific

Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test. also invest in bitcoin and have adopted bitcoin as its treasury reserve asset. Company's healthcare technology solutions business is predominant operational focus, providing cash flows and enabling it to pursue bitcoin.

Ticker

$SMLR
Primary listing

Industry

Health Care Equipment & Supplies

Employees

79

ISIN

US81684M1045

SMLR Metrics

BasicAdvanced
$565M
-
-$3.78
1.34
-

What the Analysts think about SMLR

Analyst ratings (Buy, Hold, Sell) for Semler Scientific stock.

Bulls say / Bears say

Semler Scientific's adoption of Bitcoin as a treasury asset has led to significant unrealized gains, with holdings valued at over $300 million as of February 2025, enhancing the company's financial position. (coindesk.com)
The company's QuantaFlo product maintains a strong market position, providing a competitive edge in the medical technology sector. (seekingalpha.com)
Semler Scientific reported a substantial increase in earnings per share (EPS) to $3.41 in Q4 2024, significantly surpassing analyst expectations and indicating robust financial health. (techdows.com)
The company's heavy investment in Bitcoin introduces significant financial risk due to the cryptocurrency's volatility, potentially impacting overall financial stability. (seekingalpha.com)
Semler Scientific's issuance of $85 million in convertible senior notes to fund Bitcoin purchases has led to shareholder dilution and raised concerns about the company's strategic focus. (coindesk.com)
Institutional investors, such as Russell Investments Group Ltd. and Bank of New York Mellon Corp, have reduced their stakes in Semler Scientific, potentially indicating decreased confidence in the company's direction. (defenseworld.net, defenseworld.net)
Data summarised monthly by Lightyear AI. Last updated on 9 Jun 2025.

SMLR Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

SMLR Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $SMLR

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs